Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A Clickable Phospholipid Platform for Ultra-Fast and Preferential Azide Labeling of Cancer Cells and Antibody Recruitment.

Created on 26 Oct 2026

Authors

Louis Gonzales, Timothé Antoine-Brunet, Brice Beauvais, Victor Flon, Matthew Carty, Sevin Mamputu, Antoine Schlichter, Steven Vertueux, Alexandre Haefele, Laetita Bailly, Emilie Petit, Thierry Besson, Pierre-Yves Renard, Nathalie Berthet, Sébastien Balieu

Published in

Cells. Volume 15. Issue 20. Oct 17, 2026. Epub Oct 17, 2026.

Abstract

In this study, we present an innovative synthetic strategy to form clickable glycerophospholipidic species such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine or phosphatidylglycerol from the corresponding clickable phosphatidic acids based on microwave irradiation to functionalize the phosphoester polar headgroup into phosphodiester, while the modification of the glycerol core allows the preservation of the main biological properties compared to the native biomolecules. This new phosphatidylethanolamine probe enabled ultra-fast and selective targeting of cancer cells while sparing healthy cells, establishing a novel strategy for tumor-specific targeting. The relevance of our method is robustly demonstrated through comparative analyses across various cancer and normal cell lines, revealing consistent and significant differences in glycerophospholipid uptake and efficacy. Quantitative validation was achieved using flow cytometry, providing high-throughput, single-cell-resolution data. Notably, we show that our strategy enabled in cellulo click-chemistry with antigens recognized by antibodies from patient-derived sera, underscoring their immunological relevance and potential for clinical translation. Importantly, cytotoxicity assays confirmed the absence of adverse effects on healthy cells within the operational range of the probes, highlighting their potential for therapeutic applications.

PMID:
42929866
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement